Talcum Powder Link to Ovarian Cancer Lawsuits
Johnson & Johnson Faces Growing Ovarian Cancer Litigation
Johnson & Johnson is facing more than 1,200 lawsuits filed by women diagnosed with ovarian cancer who allege long-term use of Johnson’s Baby Powder or Johnson’s Shower to Shower talcum powder products for feminine hygiene.
The lawsuits claim that prolonged genital use of talc-based products exposed women to serious health risks that were not adequately disclosed.
Scientific Studies Linking Talc to Ovarian Cancer
Concerns about talcum powder and ovarian cancer are not new. In 1971, British researchers examined 13 ovarian tumors and found talc particles deeply embedded in 10 of them.
In 1982, the medical journal Cancer published a study identifying a potential link between the genital use of talc and ovarian cancer. The lead author of that study, a gynecologist affiliated with Harvard Medical School, later conducted additional research that found a 33% higher rate of ovarian cancer among women who used talc for feminine hygiene.
Ovarian Cancer Statistics and Public Health Impact
Each year, more than 22,000 women in the United States are diagnosed with ovarian cancer. Tragically, over half of those women will die from the disease.
Plaintiffs in talcum powder litigation allege that talc exposure may be a contributing cause in many of these cases, particularly where talcum powder was used regularly for feminine hygiene over long periods of time.
Legal Help for Talcum Powder–Related Cancer Claims
The attorneys at Strauss Troy have significant experience litigating cases involving pharmaceutical products and medical devices.
If you or a loved one has been diagnosed with ovarian cancer and has a history of using talcum powder products for feminine hygiene, Strauss Troy would like to speak with you. There is no charge for the investigation of a potential case.
For more information, contact:
Ronald R. Parry
Strauss Troy
513-621.2120 (Office)
.png)
.png)